The predicting value of post neoadjuvant treatment magnetic resonance imaging: a meta-analysis.
Yaniv ZagerNir HoreshMichael AbdelmassehChristopher T AquinaBustamante Lopez Leonardo AlfonsoMark K SolimanMatthew R AlbertJohn R T MonsonPublished in: Surgical endoscopy (2024)
Our findings suggest that the concordance rates between restaging MRI and pathological outcomes in rectal cancer patients following neoadjuvant therapy are limited. Caregivers should take these results into consideration when making clinical decisions about these patients. More data should be gathered about the predictive value of MRI after total neoadjuvant therapy as well as immunotherapy in rectal cancer patients.
Keyphrases
- rectal cancer
- magnetic resonance imaging
- locally advanced
- contrast enhanced
- lymph node
- end stage renal disease
- ejection fraction
- diffusion weighted imaging
- newly diagnosed
- palliative care
- prognostic factors
- peritoneal dialysis
- radiation therapy
- squamous cell carcinoma
- metabolic syndrome
- electronic health record
- mesenchymal stem cells
- stem cells
- bone marrow
- combination therapy
- deep learning
- artificial intelligence
- weight loss